LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
100 hedge funds and large institutions have $871M invested in La Jolla Pharmaceutical Company in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
56% less call options, than puts
Call options by funds: $5.85M | Put options by funds: $13.4M
Holders
100
Holding in Top 10
5
Calls
$5.85M
Puts
$13.4M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$27.3M | |
| 3 | +$20.8M | |
| 4 |
BC
Broadfin Capital
New York
|
+$18.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$18.6M |
Top Sellers
| 1 | -$66.9M | |
| 2 | -$8.4M | |
| 3 | -$6.44M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.8M |
| 5 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$1.75M |